NCT07589153

Brief Summary

This prospective randomized controlled trial aims to compare the clinical efficacy and safety of Percutaneous Nephrolithotomy (PCNL) and Retrograde Intrarenal Surgery (RIRS) for renal stones measuring 10-20 mm. The study specifically investigates whether the anatomical location of the stone (upper, middle, or lower calyx) influences the success rates and stone-free outcomes of these two surgical modalities. A total of 110 patients were randomized into two equal groups to evaluate primary endpoints, including stone-free rates at the 3-month follow-up, and secondary endpoints such as operative time and complication rates

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2012

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
12.5 years until next milestone

First Submitted

Initial submission to the registry

May 10, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

1.4 years

First QC Date

May 10, 2026

Last Update Submit

May 10, 2026

Conditions

Keywords

Kidney Calculi Nephrolithiasis Urolithiasis Renal Stone

Outcome Measures

Primary Outcomes (1)

  • Stone-Free Rate (SFR)

    The percentage of patients who are completely free of stones or have only clinically insignificant residual fragments (less than 3 mm). This will be evaluated using non-contrast computed tomography (NCCT)

    3 months postoperatively

Secondary Outcomes (4)

  • Total Operative Duration

    During the surgical procedure (intraoperative)

  • Change in Hemoglobin Levels

    Within 24 hours postoperatively.

  • Postoperative Complications

    From surgery up to 30 days postoperatively.

  • Length of Hospital Stay

    From the day of surgery until hospital discharge (typically 1-3 days).

Study Arms (2)

PCNL Group

EXPERIMENTAL

Patients in this group underwent Percutaneous Nephrolithotomy (PCNL) for the treatment of renal stones measuring 10-20 mm. The procedure was performed in the prone or lithotomy position under general anesthesia.

Device: Percutaneous Nephrolithotomy (PCNL)

RIRS Group

ACTIVE COMPARATOR

Patients in this group underwent Retrograde Intrarenal Surgery (RIRS) using a flexible ureterorenoscope and laser lithotripsy for the treatment of renal stones measuring 10-20 mm.

Device: Retrograde Intrarenal Surgery (RIRS)

Interventions

A standard percutaneous approach was used. Under general anesthesia, a nephrostomy tract was established, and the stone was fragmented using a pneumatic or ultrasonic lithotripter.

PCNL Group

The procedure was performed using a flexible ureterorenoscope. Stones were fragmented using a Holmium:YAG laser fiber after reaching the renal pelvis and calyces retrogradely.

RIRS Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or older. Presence of a single, non-staghorn radiopaque renal stone measuring 10-20 mm in diameter.
  • Stone location in the upper, middle, or lower renal calyx. Patients who provided written informed consent.

You may not qualify if:

  • Patients with untreated urinary tract infections or urosepsis. Patients with uncorrected bleeding disorders or receiving anticoagulant therapy.
  • Presence of severe skeletal deformities preventing surgical positioning. Patients with morbid obesity (BMI \> 40 kg/m²). Presence of anatomical abnormalities (e.g., horseshoe kidney, ectopic kidney). Pregnancy. Multiple renal stones or stones larger than 20 mm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Nephrolithotomy, Percutaneous

Intervention Hierarchy (Ancestors)

LaparoscopyEndoscopyMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeUrologic Surgical ProceduresUrogenital Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Faculty of Health Sciences, Department of Nursing

Study Record Dates

First Submitted

May 10, 2026

First Posted

May 15, 2026

Study Start

May 1, 2012

Primary Completion

September 15, 2013

Study Completion

November 1, 2013

Last Updated

May 15, 2026

Record last verified: 2026-05